Literature DB >> 22340433

Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase.

Verónica Barrioluengo1, Yi Wang, Stuart F J Le Grice, Luis Menéndez-Arias.   

Abstract

Although recent reports have provided strong evidence to suggest that xenotropic murine leukemia virus-related virus (XMRV) is unlikely to be the causative agent of prostate cancer and chronic fatigue syndrome, this recombinant retrovirus can nonetheless infect human cells in vitro and induce a chronic infection in macaques. In the present study, we determined the accuracy of DNA synthesis of the reverse transcriptases (RTs) of XMRV and Moloney murine leukemia virus (MoMLV) using a combination of pre-steady-state kinetics of nucleotide incorporation and an M13mp2-based forward mutation assay. The results obtained were compared with those previously reported for the HIV type 1 BH10 strain (HIV-1(BH10)) RT. MoMLV and XMRV RTs were 13.9 and 110 times less efficient [as determined by the catalytic rate constant of the nucleotide incorporation reaction ((pol))/equilibrium constant (K(d))] than the HIV-1(BH10) RT in incorporating correct nucleotides. Misinsertion and mispair extension kinetic studies demonstrated that MoMLV RT was more accurate than the HIV-1(BH10) RT. In comparison with the MoMLV RT, the XMRV RT showed decreased mispair extension fidelity and was less faithful when misincorporating C or A opposite A. However, the XMRV RT showed stronger selectivity against G in misinsertion fidelity assays. Forward mutation assays revealed that XMRV and MoMLV RTs had similar accuracy of DNA-dependent DNA synthesis, but were > 13 times more faithful than the HIV-1(BH10) enzyme. The mutational spectra of XMRV and MoMLV RTs were similar in having a relatively higher proportion of frameshifts and transversions compared with the HIV-1(BH10) RT. However, the XMRV polymerase was less prone to introduce large deletions and one-nucleotide insertions.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340433      PMCID: PMC3323693          DOI: 10.1111/j.1742-4658.2012.08532.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  42 in total

1.  Direct determination of the point mutation rate of a murine retrovirus.

Authors:  R J Monk; F G Malik; D Stokesberry; L H Evans
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.

Authors:  Graham Simmons; Simone A Glynn; Anthony L Komaroff; Judy A Mikovits; Leslie H Tobler; John Hackett; Ning Tang; William M Switzer; Walid Heneine; Indira K Hewlett; Jiangqin Zhao; Shyh-Ching Lo; Harvey J Alter; Jeffrey M Linnen; Kui Gao; John M Coffin; Mary F Kearney; Francis W Ruscetti; Max A Pfost; James Bethel; Steven Kleinman; Jerry A Holmberg; Michael P Busch
Journal:  Science       Date:  2011-09-22       Impact factor: 47.728

3.  Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro.

Authors:  J D Roberts; B D Preston; L A Johnston; A Soni; L A Loeb; T A Kunkel
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

4.  Recombinant origin of the retrovirus XMRV.

Authors:  Tobias Paprotka; Krista A Delviks-Frankenberry; Oya Cingöz; Anthony Martinez; Hsing-Jien Kung; Clifford G Tepper; Wei-Shau Hu; Matthew J Fivash; John M Coffin; Vinay K Pathak
Journal:  Science       Date:  2011-05-31       Impact factor: 47.728

Review 5.  Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome.

Authors:  Luis Menéndez-Arias
Journal:  Rev Med Virol       Date:  2010-11-26       Impact factor: 6.989

Review 6.  Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.

Authors:  Marie L Coté; Monica J Roth
Journal:  Virus Res       Date:  2008-02-21       Impact factor: 3.303

7.  Mechanism and fidelity of HIV reverse transcriptase.

Authors:  W M Kati; K A Johnson; L F Jerva; K S Anderson
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

8.  Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependent.

Authors:  M Ricchetti; H Buc
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

9.  Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection.

Authors:  Jeremy A Garson; Paul Kellam; Greg J Towers
Journal:  Retrovirology       Date:  2011-02-25       Impact factor: 4.602

10.  Mutation rates and intrinsic fidelity of retroviral reverse transcriptases.

Authors:  Luis Menéndez-Arias
Journal:  Viruses       Date:  2009-12-04       Impact factor: 5.048

View more
  3 in total

1.  Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases.

Authors:  Mar Álvarez; Alba Sebastián-Martín; Guillermo García-Marquina; Luis Menéndez-Arias
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

2.  Evolution of HIV-1 within untreated individuals and at the population scale in Uganda.

Authors:  Jayna Raghwani; Andrew D Redd; Andrew F Longosz; Chieh-Hsi Wu; David Serwadda; Craig Martens; Joseph Kagaayi; Nelson Sewankambo; Stephen F Porcella; Mary K Grabowski; Thomas C Quinn; Michael A Eller; Leigh Anne Eller; Fred Wabwire-Mangen; Merlin L Robb; Christophe Fraser; Katrina A Lythgoe
Journal:  PLoS Pathog       Date:  2018-07-27       Impact factor: 6.823

3.  Transcriptional inaccuracy threshold attenuates differences in RNA-dependent DNA synthesis fidelity between retroviral reverse transcriptases.

Authors:  Alba Sebastián-Martín; Verónica Barrioluengo; Luis Menéndez-Arias
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.